There is 1 paper on CAFs senescence-associated risk signature in aging research: none in people yet, 1 in cells.
1 paper studies it2 findings
See all 1 papers on CAFs senescence-associated risk signature
- Cells1
Effects
2Immunotherapy response
downin silico1
1 study
Immunotherapy response
downin silico1
CAFs senescence-associated risk signature decreases immunotherapy response in silico (bioinformatics analysis).
In silicobioinformatics analysis
Prognosis
downin silico1
1 study
Prognosis
downin silico1
CAFs senescence-associated risk signature impairs prognosis in training and validation cohorts.
In silicoin training and validation cohorts